消化管ステント市場の評価：製品・素材・用途・エンドユーザー・地域別の機会および予測 (2017～2031年)

世界の消化管ステントの市場規模は、2023年の5億1,583万米ドルから、2024年から2031年の予測期間中は5.35%のCAGRで推移し、2031年には7億8,268万米ドルの規模に成長すると予測されています。

消化管ステント市場は、胃腸障害や消化器疾患の有病率の上昇、低侵襲外科手術への嗜好の高まりなどの原動力のもと、顕著な成長を記録すると予測されています。消化器疾患の有病率は、消化器疾患にかかるリスクの高い高齢者人口の増加や、加工食品を含む不健康な食品の多量摂取など、いくつかの要因によって上昇しています。胃腸障害はまた、食習慣の変化、ライフスタイルの変化、病原菌、加工食品や寿司などの生ものの摂取といった要因によっても増加しています。医療機器、特にステントの設計や素材における技術の進歩も、市場の成長をさらに促進しています。自己拡張型金属ステントなどの先端材料の使用により、最小外科手術用の消化管ステントの人気がさらに高まっています。一方で、高額な手術費用や新興国での償還の制限による経済的な問題が市場の成長を妨げています。医療機器の承認と開発に関する厳しい規制が主要企業の事業拡大を妨げることもあります。こうした課題にもかかわらず、市場は今後飛躍的に成長すると予想されています。

胃腸疾患の有病率の上昇

胃腸障害や消化器疾患の有病率は増加傾向にあり、ライフスタイルの変化が大きな要因となっています。この増加は、ペースの速いライフスタイル、食生活の乱れ、COVID-19の影響などによるストレスといった要因と関連しています。過敏性腸症候群 (IBS) 、胃食道逆流症 (GERD) 、大腸癌などの特定の疾患は、顕著に罹患率が増加しています。これらの疾患の管理には、バランスのとれた食事、定期的な運動、十分な睡眠などの生活習慣の改善が推奨されます。これらの疾患は時に消化管の閉塞につながり、ステントを用いて外科的に除去されます。消化管疾患の有病率の上昇に伴い、消化管ステントに対する需要が高まり、市場の成長が見込まれています。National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) によると、米国では約6,000万人から7,000万人が消化器系疾患に罹患しています。

低侵襲手術への嗜好の高まり

低侵襲性外科処置への嗜好の高まりが、消化管ステントの需要を牽引しています。低侵襲の消化管手術は、従来の開腹手術と比較して、その有効性、入院期間の短縮、術後死亡率の低下、回復の早さなどから好まれています。生分解性ステントや薬剤溶出性ステントの開発といった技術の開発や新興経済諸国における医療部門の成長が、低侵襲外科手術の人気をさらに高め、消化管ステント市場の拡大を後押ししています。

当レポートでは、世界の消化管ステントの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の消化管ステント市場の展望

• 市場規模・予測
• 製品別
  • 胆管ステント
  • 十二指腸ステント
  • 結腸ステント
  • 膵臓ステント
  • 食道ステント
• 素材別
  • 自己拡張型金属ステント
  • プラスチックステント
• 用途別
  • 胆道疾患
  • 過敏性腸症候群
  • 消化器癌
  • 結腸直腸癌
  • 胃癌
  • 食道癌
  • 膵臓癌
• エンドユーザー別
  • 病院・診療所
  • 外来手術センター
• 地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ
• 企業別の市場シェア

第5章 世界の消化管ステント市場の展望：地域別

• 北米
• 欧州
• 南米
• アジア太平洋
• 中東・アフリカ

第6章 市場マッピング

• 製品別
• 素材別
• 用途別
• エンドユーザー別
• 地域別

第7章 マクロ環境と産業構造

• 需給分析
• 輸出入分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

• 成長促進要因
• 成長阻害要因 (課題・抑制要因)

第9章 規制の枠組みとイノベーション

• 臨床試験
• 特許の情勢
• 規制当局の承認
• イノベーション/新興技術

第10章 主要企業の情勢

• 市場リーダー上位5社の競合マトリックス
• 市場リーダー上位5社の市場収益分析
• M&A・ジョイントベンチャー (該当する場合)
• SWOT分析 (主要企業)

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

• Boston Scientific Corporation
• Olympus Corporation
• Merit Medical Systems
• Medtronic Plc
• Terumo Corporation
• Johnson & Johnson Services, Inc.,
• M Inc.
• Smith & Nephew
• Medline Industries, Inc.
• B. Braun Melsungen AG
• Danaher Corporation

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1.Global Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 2.Global Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 3.Global Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 4.Global Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 5.Global Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 6.Global Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 7.Global Gastrointestinal Stent Market Share (%), By Region, 2017-2031F
• Figure 8.North America Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 9.North America Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 10.North America Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 11.North America Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 12.North America Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 13.North America Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 14.North America Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
• Figure 15.United States Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 16.United States Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 17.United States Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 18.United States Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 19.United States Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 20.United States Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 21.Canada Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 22.Canada Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 23.Canada Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 24.Canada Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 25.Canada Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 26.Canada Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 27.Mexico Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 28.Mexico Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 29.Mexico Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 30.Mexico Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 31.Mexico Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 32.Mexico Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 33.Europe Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 34.Europe Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 35.Europe Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 36.Europe Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 37.Europe Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 38.Europe Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 39.Europe Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
• Figure 40.Germany Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 41.Germany Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 42.Germany Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 43.Germany Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 44.Germany Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 45.Germany Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 46.France Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 47.France Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 48.France Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 49.France Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 50.France Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 51.France Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 52.Italy Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 53.Italy Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 54.Italy Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 55.Italy Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 56.Italy Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 57.Italy Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 58.United Kingdom Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 59.United Kingdom Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 60.United Kingdom Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 61.United Kingdom Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 62.United Kingdom Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 63.United Kingdom Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 64.Russia Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 65.Russia Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 66.Russia Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 67.Russia Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 68.Russia Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 69.Russia Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 70.Netherlands Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 71.Netherlands Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 72.Netherlands Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 73.Netherlands Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 74.Netherlands Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 75.Netherlands Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 76.Spain Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 77.Spain Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 78.Spain Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 79.Spain Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 80.Spain Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 81.Spain Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 82.Turkey Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 83.Turkey Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 84.Turkey Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 85.Turkey Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 86.Turkey Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 87.Turkey Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 88.Poland Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 89.Poland Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 90.Poland Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 91.Poland Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 92.Poland Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 93.Poland Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 94.South America Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 95.South America Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 96.South America Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 97.South America Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 98.South America Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 99.South America Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 100.South America Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
• Figure 101.Brazil Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 102.Brazil Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 103.Brazil Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 104.Brazil Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 105.Brazil Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 106.Brazil Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 107.Argentina Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 108.Argentina Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 109.Argentina Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 110.Argentina Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 111.Argentina Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 112.Argentina Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 113.Asia-Pacific Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 114.Asia-Pacific Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 115.Asia-Pacific Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 116.Asia-Pacific Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 117.Asia-Pacific Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 118.Asia-Pacific Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 119.Asia-Pacific Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
• Figure 120.India Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 121.India Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 122.India Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 123.India Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 124.India Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 125.India Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 126.China Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 127.China Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 128.China Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 129.China Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 130.China Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 131.China Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 132.Japan Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 133.Japan Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 134.Japan Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 135.Japan Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 136.Japan Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 137.Japan Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 138.Australia Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 139.Australia Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 140.Australia Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 141.Australia Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 142.Australia Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 143.Australia Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 144.Vietnam Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 145.Vietnam Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 146.Vietnam Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 147.Vietnam Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 148.Vietnam Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 149.Vietnam Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 150.South Korea Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 151.South Korea Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 152.South Korea Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 153.South Korea Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 154.South Korea Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 155.South Korea Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 156.Indonesia Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 157.Indonesia Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 158.Indonesia Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 159.Indonesia Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 160.Indonesia Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 161.Indonesia Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 162.Philippines Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 163.Philippines Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 164.Philippines Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 165.Philippines Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 166.Philippines Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 167.Philippines Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 168.Middle East & Africa Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 169.Middle East & Africa Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 170.Middle East & Africa Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 171.Middle East & Africa Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 172.Middle East & Africa Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 173.Middle East & Africa Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 174.Middle East & Africa Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
• Figure 175.Saudi Arabia Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 176.Saudi Arabia Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 177.Saudi Arabia Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 178.Saudi Arabia Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 179.Saudi Arabia Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 180.Saudi Arabia Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 181.UAE Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 182.UAE Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 183.UAE Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 184.UAE Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 185.UAE Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 186.UAE Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 187.South Africa Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
• Figure 188.South Africa Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
• Figure 189.South Africa Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
• Figure 190.South Africa Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
• Figure 191.South Africa Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
• Figure 192.South Africa Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
• Figure 193.By Product Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 194.By Material Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 195.By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 196.By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 197.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Global gastrointestinal stent market is projected to witness a CAGR of 5.35% during the forecast period 2024-2031, growing from USD 515.83 million in 2023 to USD 782.68 million in 2031. The gastrointestinal stent market is anticipated to register notable growth under driving forces like the rising prevalence of gastrointestinal disorders and digestive diseases, and the increasing preference for minimally invasive surgical procedures. The prevalence of gastrointestinal disorders is rising due to several factors, such as the growing geriatric population, which is at high risk of catching digestive problems, and high intake of unhealthy food, including processed food. Gastrointestinal disorders are also increasing due to factors such as changing food habits, lifestyle changes, pathogens, and intake of processed food and raw meat, for example, sushi. Technological advancements in the design and material of medical devices, specifically stents, have further enhanced the market growth. The use of advanced materials, such as self-expanding metal stents, has further increased the popularity of gastrointestinal stents for minimally surgical procedures. However, affordability issues due to high procedure costs and limited reimbursement in developing countries hinder market growth. Stringent regulations for the approval and development of medical devices sometimes hinder the expansion of key players. Despite these challenges, the market is expected to grow exponentially in future years.

For instance, in October 2020, Olympus Corporation, which is a global technology leader in delivering innovative medical and surgical solutions announced the commercial launch of HANAROSTENT Esophagus TTS self-expanding metal stents (SEMS). The product is made by M.I. Tech and distribution is being taken care of by Olympus in the United States. The Through-the-Scope (TTS) esophageal stent helps achieve luminal patency in different clinical applications. It is designed to be used in the palliative treatment of trachea-esophageal fistula and esophageal stricture which are caused due to malignant tumors.

Rising Prevalence of Gastrointestinal Disorders

The prevalence of gastrointestinal disorders and digestive diseases is on the rise, with lifestyle changes being a significant contributing factor. This increase is associated with factors such as fast-paced lifestyles, poor dietary habits, and stress, including the impact of the COVID-19 pandemic. Specific conditions like irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and colorectal cancer are notably increasing in incidence. Lifestyle modifications such as maintaining a balanced diet, regular exercise, and adequate sleep are recommended to help manage these conditions. These conditions sometimes lead to blockage of the GI tract which is surgically removed using stents. With the rising gastrointestinal disease prevalence, the market is expected to expand under the growing demand for GI stents. For instance, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), around 60 to 70 million United States population is affected by digestive diseases.

As per Agappe Diagnostics, in India, about 18% of people reported having digestive problems in 2020. Men were slightly more likely to report these issues (18%) compared to women (17%). As men get older, the number of people reporting digestive problems increases significantly, especially in those aged 75 and above (20%). People with higher education levels had a lower chance of reporting digestive problems (men: 16%, women: 10%). Those who had never worked or were unemployed had a higher prevalence of digestive issues (19%). Adults with certain chronic conditions, such as stroke and arthritis, were also more likely to report digestive problems.

Increasing Preference for Minimally Invasive Surgical Procedures

The increasing preference for minimally invasive surgical procedures is driving the demand for gastrointestinal stents. Minimally invasive gastrointestinal surgeries are preferred due to their effectiveness, shorter hospital stays, lower postoperative mortality rates, and quicker recovery compared to traditional open surgeries. Advancements in technology, such as the development of biodegradable and drug-eluting stents, and the growing healthcare sector in emerging economies further contribute to the popularity of minimally invasive surgical procedures enhancing the expansion of the gastrointestinal stent market. Market players actively present innovative products for the market to expand. For instance, in May 2023, Olympus Corporation received FDA clearance for its innovative EVIS X1 endoscopy system. The system includes the GIF-1100 scope, which can be used in the upper digestive tract (esophagus, stomach, and duodenum), and the CF-HQ1100DL/I colonovideoscope, intended for use in the lower digestive tract (anus, rectum, sigmoid colon, colon, and ileocecal valve).

Dominance of Biliary Stent Segment

Biliary stents are frequently utilized in gastroenterology interventions. They are effective in treating jaundice caused by both benign and malignant conditions. These stents, made of plastic or metal, are inserted by specialists. The selection of stent material relies on the obstruction cause, with metal stents being more cost-effective for inoperable malignant cases. Manufacturers are also actively involved in innovation and product development to cater to the market requisite. For instance, in November 2021, Boston Scientific Corporation, a United States-based company, gained regulatory approval (FDA and CE mark) for its AdvanixTM Biliary Plastic Stents. These stents serve as medical devices to address benign biliary strictures, suspected or confirmed biliary malignancies (tumors), and biliary stone disease. Currently, healthcare providers in Europe and other international markets have access to these stents, and Boston Scientific intends to introduce them in the United States during the first quarter of 2022.

Self-Expandable Metal Stents is the Preferred Material

Self-expandable metal stents are commonly used in gastrointestinal stenting due to several advantages. They are small enough to be delivered through an endoscope, allowing for minimally invasive procedures. These can be coated with chemicals to prevent tumor ingrowth, making them suitable for treating defects in the GI tract caused by conditions like perforations. Compared to older plastic stents, self-expandable metal stents offer a convenient insertion technique, lower complication rates, and better compliance. These stents are designed to be permanent solutions, often used in advanced-stage cancers where surgical removal is not feasible. For instance, in May 2019, Olympus revealed two new HANAROSTENT (Self-Expanding Metal Stents) at the Digestive Disease Week (DDW) 2019 conference, expanding its EndoTherapy portfolio. These new stents are manufactured by M.I. Tech and exclusively distributed by Olympus in the U.S. after receiving the 510(K) clearance. The HANAROSTENT LowAx Colonic and Duodenal Uncovered Stents cater to advanced procedures and provide specialized stent options for colorectal conditions.

North America to be the Dominating Region

North America's advanced healthcare infrastructure, increased awareness of gastrointestinal health issues, and a growing elderly population contribute to its dominant position in the market. Factors such as a high incidence of gastrointestinal diseases, a favorable reimbursement scenario, and the presence of key market players contribute to its market dominance. FDA approvals and government support for medical device development further enhance the market growth. The major factor contributing to lead in North America is the high incidence of digestive diseases like inflammatory bowel diseases. For instance, as per an article published in Gastroenterology AGA in July 2023, inflammatory bowel disease is diagnosed in more than 0.7% of Americans while age and sex-standardized incidence of inflammatory bowel disease per 100,000 person per years was estimated to be 10.9.

Future Market Scenario (2024-2031F)

The evolution of gastrointestinal stents showcases a progressive approach towards addressing complex GI conditions through advanced design innovations. Current efforts are geared towards refining existing stent types, such as metal, plastic, and biodegradable options. One focus is on anti-migratory features that prevent stents from moving within the body, reducing potential complications. Additionally, drug-eluting stents are being developed to deliver medications directly to targeted regions, helping to combat tumor growth. Another exciting advancement is the combination of radioactive stents with brachytherapy, showing promise in extending patient survival rates. As these technologies progress, they aim to minimize complications and enhance patient outcomes associated with gastrointestinal stents. For instance, QualiMed Innovative Medizinprodukte GmbH's Biodegradable Balloon-Expandable Biliary Stent System is under clinical investigation and is anticipated to be completed in mid-2024.

Key Players Landscape and Outlook

Boston Scientific Corporation, Olympus Corporation, Merit Medical Systems, Medtronic Plc, Terumo Corporation, Johnson & Johnson Services, Inc., 3M Inc., are some of the renowned players of the gastrointestinal stent market. The market is dominated by large key players who are actively involved in the research and development of innovative products. The recent acquisition of Taewoong Medical has significantly increased the market share of Olympus Corporation. Despite the developments, there have been reports of cancellation of deals in the market.

In February 2023, Olympus Corporation, a medtech company, announced the acquisition of Taewoong Medical Co., a South Korean manufacturer of medical devices, particularly gastrointestinal metallic stents. This acquisition aims to enhance Olympus's GI EndoTherapy product portfolio, ultimately improving patient outcomes through comprehensive solutions. Taewoong will receive approximately USD 370 million in cash with USD 255.5 million paid at closing and up to USD 114.5 million based on achieving future milestones.

In May 2023, Boston Scientific canceled its planned USD 230 million acquisition of South Korean medical technology company M.I.Tech which was responsible for gastrointestinal and airway stents in Boston. The deal, which would have given Boston Scientific a 64% stake in M.I.Tech, was announced in June 2022. Boston Scientific cited regulatory obstacles as the reason for ending the acquisition. The original agreement involved Boston Scientific paying 14,500 won per M.I.Tech share, totaling 291.2 billion won. The acquisition was expected to close in the second half of 2022.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Gastrointestinal Stent Market Outlook, 2017-2031F

• 4.1.Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2.By Product
  • 4.2.1.Biliary Stents
  • 4.2.2.Duodenal Stents
  • 4.2.3.Colonic Stents
  • 4.2.4.Pancreatic Stents
  • 4.2.5.Esophageal Stents
• 4.3.By Material
  • 4.3.1.Self-Expanding Metal Stents
  • 4.3.2.Plastic Stents
• 4.4.By Application
  • 4.4.1.Biliary Diseases
  • 4.4.2.Irritable Bowel Syndrome
  • 4.4.3.Gastrointestinal Cancers
  • 4.4.4.Colorectal Cancer
  • 4.4.5.Stomach Cancer
  • 4.4.6.Esophageal Cancer
  • 4.4.7.Pancreatic Cancer
• 4.5.By End-user
  • 4.5.1.Hospitals and Clinics
  • 4.5.2.Ambulatory Surgical Centers
• 4.6.By Region
  • 4.6.1.North America
  • 4.6.2.Europe
  • 4.6.3.Asia-Pacific
  • 4.6.4.South America
  • 4.6.5.Middle East and Africa
• 4.7.By Company Market Share (%), 2023

5.Global Gastrointestinal Stent Market Outlook, By Region, 2017-2031F

• 5.1.North America*
  • 5.1.1.Market Size & Forecast
    • 5.1.1.1.By Value
    • 5.1.1.2.By Volume
  • 5.1.2.By Product
    • 5.1.2.1.Biliary Stents
    • 5.1.2.2.Duodenal Stents
    • 5.1.2.3.Colonic Stents
    • 5.1.2.4.Pancreatic Stents
    • 5.1.2.5.Esophageal Stents
  • 5.1.3.By Material
    • 5.1.3.1.Self-Expanding Metal Stents
    • 5.1.3.2.Plastic Stents
  • 5.1.4.By Application
    • 5.1.4.1.Biliary Diseases
    • 5.1.4.2.Irritable Bowel Syndrome
    • 5.1.4.3.Gastrointestinal Cancers
    • 5.1.4.4.Colorectal Cancer
    • 5.1.4.5.Stomach Cancer
    • 5.1.4.6.Esophageal Cancer
    • 5.1.4.7.Pancreatic Cancer
  • 5.1.5.By End-user
    • 5.1.5.1.Hospitals and Clinics
    • 5.1.5.2.Ambulatory Surgical Centers
  • 5.1.6.United States*
    • 5.1.6.1.Market Size & Forecast
    • 5.1.6.1.1.By Value
    • 5.1.6.1.2.By Volume
    • 5.1.6.2.By Product
    • 5.1.6.2.1.Biliary Stents
    • 5.1.6.2.2.Duodenal Stents
    • 5.1.6.2.3.Colonic Stents
    • 5.1.6.2.4.Pancreatic Stents
    • 5.1.6.2.5.Esophageal Stents
    • 5.1.6.3.By Material
    • 5.1.6.3.1.Self-Expanding Metal Stents
    • 5.1.6.3.2.Plastic Stents
    • 5.1.6.4.By Application
    • 5.1.6.4.1.Biliary Diseases
    • 5.1.6.4.2.Irritable Bowel Syndrome
    • 5.1.6.4.3.Gastrointestinal Cancers
    • 5.1.6.4.4.Colorectal Cancer
    • 5.1.6.4.5.Stomach Cancer
    • 5.1.6.4.6.Esophageal Cancer
    • 5.1.6.4.7.Pancreatic Cancer
    • 5.1.6.5.By End-user
    • 5.1.6.5.1.Hospitals and Clinics
    • 5.1.6.5.2.Ambulatory Surgical Centers
  • 5.1.7.Canada
  • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

• 5.2.Europe
  • 5.2.1.Germany
  • 5.2.2.France
  • 5.2.3.Italy
  • 5.2.4.United Kingdom
  • 5.2.5.Russia
  • 5.2.6.Netherlands
  • 5.2.7.Spain
  • 5.2.8.Turkey
  • 5.2.9.Poland
• 5.3.Asia-Pacific
  • 5.3.1.India
  • 5.3.2.China
  • 5.3.3.Japan
  • 5.3.4.Australia
  • 5.3.5.Vietnam
  • 5.3.6.South Korea
  • 5.3.7.Indonesia
  • 5.3.8.Philippines
• 5.4.South America
  • 5.4.1.Brazil
  • 5.4.2.Argentina
• 5.5.Middle East & Africa
  • 5.5.1.Saudi Arabia
  • 5.5.2.UAE
  • 5.5.3.South Africa

6.Market Mapping, 2023

• 6.1.By Product
• 6.2.By Material
• 6.3.By Application
• 6.4.By End-user
• 6.5.By Region

7.Macro Environment and Industry Structure

• 7.1.Demand Supply Analysis
• 7.2.Import Export Analysis
• 7.3.Value Chain Analysis
• 7.4.PESTEL Analysis
  • 7.4.1.Political Factors
  • 7.4.2.Economic System
  • 7.4.3.Social Implications
  • 7.4.4.Technological Advancements
  • 7.4.5.Environmental Impacts
  • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5.Porter's Five Forces Analysis
  • 7.5.1.Supplier Power
  • 7.5.2.Buyer Power
  • 7.5.3.Substitution Threat
  • 7.5.4.Threat from New Entrant
  • 7.5.5.Competitive Rivalry

8.Market Dynamics

• 8.1.Growth Drivers
• 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

• 9.1.Clinical Trials
• 9.2.Patent Landscape
• 9.3.Regulatory Approvals
• 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

• 10.1.Competition Matrix of Top Five Market Leaders
• 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4.SWOT Analysis (For Five Market Players)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

• 13.1.Boston Scientific Corporation
  • 13.1.1.Company Details
  • 13.1.2.Key Management Personnel
  • 13.1.3.Products & Services
  • 13.1.4.Financials (As reported)
  • 13.1.5.Key Market Focus & Geographical Presence
  • 13.1.6.Recent Developments
• 13.2.Olympus Corporation
• 13.3.Merit Medical Systems
• 13.4.Medtronic Plc
• 13.5.Terumo Corporation
• 13.6.Johnson & Johnson Services, Inc.,
• 13.7.3M Inc.
• 13.8.Smith & Nephew
• 13.9.Medline Industries, Inc.
• 13.10.B. Braun Melsungen AG
• 13.11.Danaher Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer